Skip to main content
News Directory 3
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
23andMe Nonprofit: Anne Wojcicki Reclaims Company - News Directory 3

23andMe Nonprofit: Anne Wojcicki Reclaims Company

June 14, 2025 Health
News Context
At a glance
  • A nonprofit association spearheaded⁤ by Anne Wojcicki, co-founder and longtime CEO of the genetic data firm 23andMe, has emerged victorious in a last-minute bidding war to⁢ acquire the...
  • The Wall Street Journal initially reported⁣ the news, which surfaces less⁤ than a ‍month ⁣after biotech giant Regeneron announced its intentions to purchase 23andMe out of bankruptcy for...
  • 23andMe officials stated that the agreement facilitated a final bidding round between the TTAM Research ⁢Institute, led by Wojcicki, and ⁣Regeneron.
Original source: statnews.com

Key Points

  • Anne‍ Wojcicki’s nonprofit ‍wins 23andMe asset bid.
  • Winning bid totals $305 million.
  • Regeneron⁣ initially planned to buy 23andMe for $256 million.

Wojcicki Nonprofit Wins Bidding War for 23andMe Assets

Updated June⁣ 14, 2025

A nonprofit association spearheaded⁤ by Anne Wojcicki, co-founder and longtime CEO of the genetic data firm 23andMe, has emerged victorious in a last-minute bidding war to⁢ acquire the majority of 23andMe’s assets. The winning bid totaled $305⁢ million, according to a company press release. This acquisition highlights⁢ the critical role Wojcicki plays in the company’s future.

The Wall Street Journal initially reported⁣ the news, which surfaces less⁤ than a ‍month ⁣after biotech giant Regeneron announced its intentions to purchase 23andMe out of bankruptcy for $256 million. The bidding process underscores the significant role of strategic acquisitions in the biotech industry.

23andMe officials stated that the agreement facilitated a final bidding round between the TTAM Research ⁢Institute, led by Wojcicki, and ⁣Regeneron. This process was designed to enable the company’s board to secure the most advantageous deal for its shareholders, ensuring the best possible outcome in this crucial⁣ role.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

biotechnology, diagnostics, genetics, Genomics, STAT+

Search:

News Directory 3

News Directory 3 catalogs US newspapers, news services, newsstands and digital news outlets across all 50 states. Browse local publishers by city, state, or topic, and follow current headlines linked back to their original sources.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

© 2026 News Directory 3. All rights reserved.
For contact, advertising, copyright, issues email: office@newsdirectory3.com